Mode
Text Size
Log in / Sign up

Transnasal transsphenoidal resection outcomes in 212 patients with non-functioning pituitary macroadenomas show variable progression ratesResearch examines pituitary tumor recurrence and stability after surgical removal

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note 35.6% progression risk in residual non-functioning pituitary macroadenomas following transsphenoidal resection in retrospective cohort.

This retrospective cohort study included 212 patients with histologically confirmed non-functioning pituitary macroadenomas at a tertiary referral center. The intervention involved transnasal transsphenoidal resection. Patients were assessed for tumor progression in postoperative residual findings over a mean follow-up of 39 months. The study design is observational, meaning associations are reported rather than causal relationships established. The comparator focused on stable residuals versus progressive residuals among the cohort.

Initial radiological gross total resection was achieved in 94/212 (44.3%) of the cohort. Durable complete resection without recurrence occurred in 62/212 (29.2%). Among patients with residual findings, 76 (64.4%) had stable tumors while 42 (35.6%) experienced progression. Recurrence after initial gross total resection was noted in 32/212 (15.1%). Tumor progression correlated with preoperative volume, showing a median of 11.6 cm3 vs 5.81 cm3 for those with larger volumes. These statistics highlight the variability in long-term outcomes following surgical intervention for this specific pathology.

Safety data regarding adverse events, serious adverse events, and discontinuations were not reported in the abstract. Limitations were not reported, though the single-center setting may affect generalizability. Practice relevance supports individualized decisions regarding follow-up and adjuvant therapy. Clinicians should note the retrospective nature when applying these findings to patient care. The lack of safety reporting requires careful consideration when weighing risks against benefits in clinical practice settings. Additional context on long-term outcomes remains limited.

Researchers looked at 212 patients treated at a single hospital for non-functioning pituitary tumors. These are tumors that do not produce excess hormones. The patients had surgery to remove the tumor tissue. On average, they were checked for about 39 months after the procedure.

About 44 percent of patients had the tumor completely removed during the first operation. However, only 29 percent remained free of tumor growth long-term. Among those with some tumor left behind, roughly 64 percent stayed stable, while 36 percent saw their tumors grow. The study found that patients with larger tumors before surgery were more likely to experience progression.

This was a retrospective study, meaning doctors looked back at past records rather than planning the care ahead of time. It was also done at just one medical center. Because of this, the results show links between factors but cannot prove cause and effect. The findings suggest doctors might use tumor size to help plan follow-up care.

Patients should discuss these numbers with their doctors to understand their own risks. This information supports personalized decisions about monitoring and treatment options. It does not guarantee outcomes for any specific person.

What this means for you:
This study links larger tumor size to growth after surgery, but results need more research.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
IntroductionThis retrospective, single-center study aimed to identify predictive factors for progression in postoperative residual findings of non-functioning pituitary macroadenomas (NFPMAs). The findings are intended to support individualized decisions regarding follow-up and adjuvant therapy.MethodsA retrospective analysis was conducted on 212 patients treated at a tertiary referral center between 2007 and 2023. Patients underwent MRI-guided, transnasal transsphenoidal surgery for histologically confirmed NFPMAs. Pre- and postoperative tumor volumes were assessed alongside demographic, clinical, and histopathological data. Tumor configuration was classified using Hardy and Knosp scales. Subgroups were defined based on postoperative imaging: stable residuals, progressive residuals, or recurrence after gross total resection (GTR). Statistical analyses included multivariate testing and ROC analysis to determine predictive cutoff values.ResultsOf the 212 patients, initial radiological gross total resection (GTR) was achieved in 94/212 (44.3%); during follow-up, 62/212 (29.2%) had durable complete resection without recurrence, while 32/212 (15.1%) developed recurrence after initial GTR. Among patients with residual findings, 76 (64.4%) exhibited stable tumors after a mean of follow-up of 39 months, while 42 (35.6%) showed progression, which correlated significantly with larger preoperative tumor volumes (median: 11.6 cm3 vs. 5.81 cm3, p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.